LY450108AMPA receptor potentiator CAS# 376594-67-1 |
- Ampalex
Catalog No.:BCC1359
CAS No.:154235-83-3
- Tezampanel
Catalog No.:BCC1993
CAS No.:154652-83-2
- Noopept
Catalog No.:BCC1804
CAS No.:157115-85-0
- Perampanel
Catalog No.:BCC1847
CAS No.:380917-97-5
- Aniracetam
Catalog No.:BCC4219
CAS No.:72432-10-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 376594-67-1 | SDF | Download SDF |
PubChem ID | 9843690 | Appearance | Powder |
Formula | C19H22F2N2O3S | M.Wt | 396.45 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 50 mg/mL (126.12 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 3,5-difluoro-N-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]benzamide | ||
SMILES | CC(C)S(=O)(=O)NCC(C)C1=CC=C(C=C1)NC(=O)C2=CC(=CC(=C2)F)F | ||
Standard InChIKey | ACOXQYLJOQAHST-ZDUSSCGKSA-N | ||
Standard InChI | InChI=1S/C19H22F2N2O3S/c1-12(2)27(25,26)22-11-13(3)14-4-6-18(7-5-14)23-19(24)15-8-16(20)10-17(21)9-15/h4-10,12-13,22H,11H2,1-3H3,(H,23,24)/t13-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | LY450108 is an alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiator.
IC50 value:
Target:
AMPA receptors mediate most of the excitatory neurotransmission and play a key role in synaptic plasticity in the mammalian central nervous system (CNS). Recent evidence has shown that in addition to modulating fast synaptic plasticity and memory processes, AMPA receptor potentiators alter downstream signalling pathways and may thereby have utility in other CNS disorders. References: |
LY450108 Dilution Calculator
LY450108 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5224 mL | 12.6119 mL | 25.2239 mL | 50.4477 mL | 63.0597 mL |
5 mM | 0.5045 mL | 2.5224 mL | 5.0448 mL | 10.0895 mL | 12.6119 mL |
10 mM | 0.2522 mL | 1.2612 mL | 2.5224 mL | 5.0448 mL | 6.306 mL |
50 mM | 0.0504 mL | 0.2522 mL | 0.5045 mL | 1.009 mL | 1.2612 mL |
100 mM | 0.0252 mL | 0.1261 mL | 0.2522 mL | 0.5045 mL | 0.6306 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
LY450108 is an alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiator. AMPA receptors mediate most of the excitatory neurotransmission and play a key role in synaptic plasticity in the mammalian central nervous system (CNS). Recent evidence has shown that in addition to modulating fast synaptic plasticity and memory processes, AMPA receptor potentiators alter downstream signalling pathways and may thereby have utility in other CNS disorders.
- BRD 7389
Catalog No.:BCC8090
CAS No.:376382-11-5
- 1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxy-3-prenylphenyl)propane
Catalog No.:BCN1450
CAS No.:376362-03-7
- 4'-O-Demethylbroussonin A
Catalog No.:BCN7364
CAS No.:376361-97-6
- 7,4'-Dihydroxy-3'-prenylflavan
Catalog No.:BCN5428
CAS No.:376361-96-5
- 5,7,2',4'-Tetrahydroxy-3-geranylflavone
Catalog No.:BCN1451
CAS No.:376361-87-4
- Maraviroc
Catalog No.:BCC3675
CAS No.:376348-65-1
- Furaltadone HCl
Catalog No.:BCC4662
CAS No.:3759-92-0
- Varenicline tartrate
Catalog No.:BCN2170
CAS No.:375815-87-5
- Phorbol 12,13-dibutyrate
Catalog No.:BCC7870
CAS No.:37558-16-0
- Boc-N-Me-Phe-OH
Catalog No.:BCC2615
CAS No.:37553-65-4
- Boc-Ala(4-pyridyl)-OH
Catalog No.:BCC3326
CAS No.:37535-57-2
- 7'(Z)-(8''R,8'''R)-epi-salvianolic acid E
Catalog No.:BCC3319
CAS No.:
- 8-Acetonyldihydrosanguinarine
Catalog No.:BCN5429
CAS No.:37687-34-6
- SU 9516
Catalog No.:BCC2398
CAS No.:377090-84-1
- Dehydroabietinol
Catalog No.:BCN5430
CAS No.:3772-55-2
- Totaradiol
Catalog No.:BCN5431
CAS No.:3772-56-3
- Rhodojaponin V
Catalog No.:BCN2807
CAS No.:37720-86-8
- Boc-Cha-OH
Catalog No.:BCC2661
CAS No.:37736-82-6
- 2-Chloro-N6-cyclopentyladenosine
Catalog No.:BCC7161
CAS No.:37739-05-2
- Questin
Catalog No.:BCN7446
CAS No.:3774-64-9
- Iristectorin A
Catalog No.:BCN8221
CAS No.:37744-61-9
- Enmein
Catalog No.:BCN3392
CAS No.:3776-39-4
- Zaprinast
Catalog No.:BCC6859
CAS No.:37762-06-4
- 2-Pentylfuran
Catalog No.:BCN3799
CAS No.:3777-69-3
Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects.[Pubmed:16554450]
J Clin Pharmacol. 2006 Apr;46(4):424-32.
The objective of this study was to measure the steady-state cerebrospinal fluid (CSF) concentration of LY450108 and LY451395 (positive modulators of AMPA receptors) in healthy subjects after the administration of 1 mg and 5 mg. Secondary objectives included the evaluation of safety, pharmacokinetics, and steady-state ratio of plasma:CSF concentrations of LY450108 and LY451395 after multiple dosing. This study was an open-label, multiple oral dose study evaluating 1 mg and 5 mg LY450108 and 1 mg and 5 mg LY451395 in 12 (3 subjects per dosing group) healthy subjects, aged 18 to 49 years. Twelve healthy male subjects completed the study. LY450108 and LY451395 were quantifiable in CSF after 1-mg and 5-mg multiple-dose administrations with plasma:CSF ratio of 82:1 and 44:1, respectively. LY450108 and LY451395 1 mg and 5 mg were measured in the CSF. Single and multiple oral doses of LY450108 and LY451395 were determined to be safe and well tolerated in healthy subjects.